FDA Inspection 819091 — Covis Pharma GmBH

Covis Pharma GmBH — FEI 3008152278

The FDA completed an inspection of Covis Pharma GmBH on February 7, 2013 in Waltham, MA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). 1 citation was issued during this inspection. Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
February 7, 2013
Fiscal Year
2013
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Waltham, MA (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)

Citations

IDCFRDescription
890721 CFR 314.81(b)(1)(ii)Contamination, chemical or physical change, deterioration